|
|
|
Recent GILD Price |
|
Gilead Sciences Price Target |
$65.94 |
+27.53% |
$84.09 |
As of 2024-04-30
Recent Analyst Ratings Breakdown |
|
Current |
1 Month Ago |
2 Months Ago |
3 Months Ago |
Strong buy ratings: |
10 |
10 |
10 |
11 |
Buy ratings: |
0 |
0 |
0 |
0 |
Hold ratings: |
14 |
14 |
14 |
11 |
Sell ratings: |
0 |
0 |
0 |
0 |
Strong sell ratings: |
0 |
0 |
0 |
0 |
Average rating: |
2.17 |
2.17 |
2.17 |
2.0 |
Average rating in the table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. For the Gilead Sciences price
target at the top of the page, we present the average target price across the 22 analysts covering GILD as reported in
data provided by Zacks Investment Research via Quandl.com. The
median price target (a different metric than the average or mean) was $81.00 as of 2024-04-30, the
highest Gilead Sciences price target in the range was $105.00 while the lowest Gilead Sciences price target in the range was
$69.00, with a standard deviation of $9.43. Get the latest Zacks research report on GILD — FREE
10 ETFs With Most Upside
To Analyst Targets
Top 25 Broker Analyst Picks of the
S&P 500
See Summary: Institutional Holders of Gilead Sciences
See Details: Top 10 Hedge Funds Holding Gilead Sciences
Also See: GILD Insider Buying
Also See: GILD Holdings Changes
|
|